4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-045773
Chief Medical Officer sold 6,250 shares at $40.00 ($250,000)
- Chief Medical Officer acquired 6,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BALDO LANCE Chief Medical Officer | 2020-08-06 | Option exercise | +6,250 | $7.80 | $48,750 | 6,250 | D |
| BALDO LANCE Chief Medical Officer | 2020-08-06 | Sale | −6,250 | $40.00 | $250,000 | 0 | D |
| Derivatives | |||||||
| BALDO LANCE Chief Medical Officer | 2020-08-06 | Option exercise · Stock Option (Right to Buy) | −6,250 | 431,250 | D | ||
| Open-market sales · 6,250 sh · avg $40.00 · $250,000 | |||||||
Loading xslF345X03/doc4.xml…